 |
|
Natural, soy-based substance might help fight MS, Jefferson neuroscientists find
December 13, 2006(PHILADELPHIA) - A natural substance made from soy appears to have amazing restorative powers when given to animals with a multiple sclerosis (MS)-like disease.
Using an animal model of MS, neurologists at Jefferson Medical College found that giving doses of a substance called Bowmann-Birk Inhibitor Concentrate (BBIC) dramatically improved the animals' ability to move and walk. The scientists, led by A. M. Rostami, M.D., Ph.D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and the Jefferson Hospital for Neuroscience in Philadelphia, say the treatment's effects may be useful in conjunction with more mainstream therapies such as beta-interferon in helping patients with MS. They report their findings December 12, 2006 in the journal Multiple Sclerosis.
MS, one of the most common neurological diseases affecting young adults, is thought to be an autoimmune disease (in which the body attacks its own tissue) affecting the central nervous system (CNS). In MS, the myelin coating of nerve fibers becomes inflamed and scarred. As a result, "messages" cannot be sent through the nervous system.
Dr. Rostami, who is also director of the Neuroimmunology Laboratory in the Department of Neurology at Jefferson Medical College, and his group used an animal model of experimental autoimmune encephalomyelitis (EAE), which mimics MS, to investigate BBIC's potential immune system-suppressing properties. BBIC inhibits proteases, enzymes that play important roles in the inflammation and demyelination processes that are at the heart of MS. It has been used for other conditions, notably precancerous conditions in the mouth.
He and his co-workers compared two groups of animals with EAE. One group received BBIC, while the other received only an inert substance. "Animals that received BBIC were able to walk while those that didn't get the drug were not," he says. He notes that the animals aren't cured but can walk with some limp or weakness. "The results are promising because this is a safe, natural compound from soybean and is given orally."
Further analysis revealed that the central nervous systems of animals that received BBIC showed "significantly less inflammation and demyelination" than those that didn't receive the therapy. "It's the first time that BBIC has been used in an EAE model and has shown significant disease suppression, and we hope it can eventually be used in humans," says Dr. Rostami. His group's next step is to design clinical trials in humans.
The scientists are not sure how BBIC works in multiple sclerosis, but they theorize that it suppresses the immune response to some extent, in addition to inhibiting proteases. Dr. Rostami sees BBIC as being used as a single therapy or in conjunction with other drugs in treating MS. He notes that because current therapies for MS involve injecting drugs such as interferon and copaxane, one goal is to develop an oral agent. BBIC could be given by pill daily.
Over 400,000 Americans acknowledge having MS, though nearly one million Americans may be living with the disease. Symptoms can include fatigue, loss of coordination, muscle weakness, numbness, inability to walk or use hands and arms, pain, vision problems, slurred speech and bladder/bowel dysfunction.
Thomas Jefferson University
Dr. Rostami, who is also director of the Neuroimmunology Laboratory in the Department of Neurology at Jefferson Medical College, and his group used an animal model of experimental autoimmune encephalomyelitis (EAE), which mimics MS, to investigate BBIC's potential immune system-suppressing properties. BBIC inhibits proteases, enzymes that play important roles in the inflammation and demyelination processes that are at the heart of MS. It has been used for other conditions, notably precancerous conditions in the mouth.
He and his co-workers compared two groups of animals with EAE. One group received BBIC, while the other received only an inert substance. "Animals that received BBIC were able to walk while those that didn't get the drug were not," he says. He notes that the animals aren't cured but can walk with some limp or weakness. "The results are promising because this is a safe, natural compound from soybean and is given orally."
Further analysis revealed that the central nervous systems of animals that received BBIC showed "significantly less inflammation and demyelination" than those that didn't receive the therapy. "It's the first time that BBIC has been used in an EAE model and has shown significant disease suppression, and we hope it can eventually be used in humans," says Dr. Rostami. His group's next step is to design clinical trials in humans.
The scientists are not sure how BBIC works in multiple sclerosis, but they theorize that it suppresses the immune response to some extent, in addition to inhibiting proteases. Dr. Rostami sees BBIC as being used as a single therapy or in conjunction with other drugs in treating MS. He notes that because current therapies for MS involve injecting drugs such as interferon and copaxane, one goal is to develop an oral agent. BBIC could be given by pill daily.
Over 400,000 Americans acknowledge having MS, though nearly one million Americans may be living with the disease. Symptoms can include fatigue, loss of coordination, muscle weakness, numbness, inability to walk or use hands and arms, pain, vision problems, slurred speech and bladder/bowel dysfunction.
Thomas Jefferson University
Neuroscientists Current Events and Neuroscientists News RSSStudy shows new brain connections form rapidly during motor learning
New connections begin to form between brain cells almost immediately as animals learn a new task, according to a study published this week in Nature.
Theory about long and short-term memory questioned by UCL scientists
The long-held theory that our brains use different mechanisms for forming long-term and short-term memories has been challenged by new research from UCL, published today in PNAS.
Changes in brain chemicals mark shifts in infant learning
When do you first leave the nest? Early in development infants of many species experience important transitions-such as learning when to leave the protective presence of their mother to start exploring the wider world.
Fighting Sleep, Penn Researchers Reverse the Cognitive Impairment Caused By Sleep Deprivation
A research collaboration led by biologists and neuroscientists at the University of Pennsylvania has found a molecular pathway in the brain that is the cause of cognitive impairment due to sleep deprivation.
General anesthetics lead to learning disabilities in animal models
Studies by researchers at Wake Forest University School of Medicine have shown that blocking the NMDA receptor in immature rats leads to profound, rapid brain injury and disruption of auditory function as the animals mature.
Alzheimer's lesions found in the retina
The eyes may be the windows to the soul, but new research indicates they also may mirror a brain ravaged by Alzheimer's disease.
Time-Keeping Brain Neurons Discovered
Groups of neurons that precisely keep time have been discovered in the primate brain by a team of researchers that includes Dezhe Jin, assistant professor of physics at Penn State University and two neuroscientists from the RIKEN Brain Science Institute in Japan and the Massachusetts Institute of Technology (MIT).
MIT neuroscientists find neural stopwatch in the brain
MIT researchers have identified populations of neurons that code time with extreme precision in the primate brain. These neurons are found in two interconnected brain regions, the prefrontal cortex and the striatum, both of which are known to play critical roles in learning, movement, and thought control.
Like humans, monkeys fall into the 'uncanny valley'
Princeton University researchers have come up with a new twist on the mysterious visual phenomenon experienced by humans known as the "uncanny valley." The scientists have found that monkeys sense it too.
Case Western Reserve University discovers Merkel cell originates from skin, not the neural crest
Case Western Reserve University School of Medicine assistant professor of pediatrics, neurosciences and otolaryngology, Stephen M. Maricich, M.D., Ph.D., and his team found that Merkel cells originate in the skin, not the neural crest lineage, as previously speculated.
More Neuroscientists Current Events and Neuroscientists News Articles
 |
Proust Was a Neuroscientist by Jonah Lehrer (Author) In this technology-driven age, it’s tempting to believe that science can solve every mystery. After all, science has cured countless diseases and even sent humans into space. But as Jonah Lehrer argues in this sparkling debut, science is not the only path to knowledge. In fact, when it comes to understanding the brain, art got there first. Taking a group of artists — a painter, a poet, a chef, a composer, and a handful of novelists — Lehrer shows how each one discovered an essential truth about the mind that science is only now rediscovering. We learn, for example, how Proust first revealed the fallibility of memory; how George Eliot discovered the brain’s malleability; how the French chef Escoffier discovered umami (the fifth taste); how Cézanne worked out the subtleties... |
 |
Silicon Vision: Computational Neuroscientist Misha Mahowald (Discovering Women, The WGBH Collection) Also With: Misha Mahowald (Primary Contributor) |
 |
Iconoclast: A Neuroscientist Reveals How to Think Differently by Gregory Berns (Author) No organization can survive without iconoclasts -- innovators who single-handedly upturn conventional wisdom and manage to achieve what so many others deem impossible. Though indispensable, true iconoclasts are few and far between. In Iconoclast, neuroscientist Gregory Berns explains why. He explores the constraints the human brain places on innovative thinking, including fear of failure, the urge to conform, and the tendency to interpret sensory information in familiar ways. Through vivid accounts of successful innovators ranging from glass artist Dale Chihuly to physicist Richard Feynman to country/rock trio the Dixie Chicks, Berns reveals the inner workings of the iconoclast's mind with remarkable clarity. Each engaging chapter goes on to describe practical actions we... |
 |
Unleashing CREATIVITY Directed By: Phyllis Lane, Alejandra Nash |
 |
How God Changes Your Brain: Breakthrough Findings from a Leading Neuroscientist by Andrew Newberg M.D. (Author), Mark Robert Waldman (Author) God is great–for your mental, physical, and spiritual health. That’s the finding of this startling, authoritative, and controversial book by the bestselling authors of Born to Believe. Based on new evidence culled from their brain-scan studies on memory patients and meditators, their Web-based survey of people’s religious and spiritual experiences, and their analyses of adult drawings of God, neuroscientist Andrew Newberg, therapist Mark Robert Waldman, and their research team have concluded that active and positive spiritual belief changes the human brain for the better. What’s more, actual faith isn’t always necessary: atheists who meditate on positive imagery can obtain similar neurological benefits. Written in an accessible style–with illustrations highlighting how... |
 |
Think Smart: A Neuroscientist's Prescription for Improving Your Brain's Performance by Richard Restak (Author) A leading neuroscientist and New York Times-bestselling author of Mozart's Brain and the Fighter Pilot distills the research on the brain and serves up practical, surprising, and illuminating recommendations for warding off neurological decline, cognitive function, and encouraging smarter thinking day to day. In Think Smart, the renowned neuropsychiatrist and bestselling author Dr. Richard Restak details how each of us can improve and tone our body's most powerful organ: the brain. As a renowned expert on the brain, Restak knows that in the last five years there have been exciting new scientific discoveries about the brain and its performance. So he's asked his colleagues-many of them the world's leading brain scientists and researchers-one important question: What can I... |
|
|
Unleashing CREATIVITY Directed By: Phyllis Lane, Alejandra Nash |
 |
Matlab for Neuroscientists: An Introduction to Scientific Computing in Matlab by Pascal Wallisch (Author), Michael Lusignan (Author), Marc Benayoun (Author), Tanya I. Baker (Author), Adam Seth Dickey (Author), Nicho Hatsopoulos (Author) Matlab is the accepted standard for scientific computing, used globally in virtually all Neuroscience and Cognitive Psychology laboratories. For instance, SPM, the most used software for the analysis and manipulation of fMRI images in research and clinical practice is fully programmed in matlab, and its use of the possibility to allow for sophisticated software modules to be freely added to the software has established it as the by far dominant software in the field. Many universities now offer, or are beginning to offer matlab introductory courses in their neuroscience and psychology programs. Nevertheless, so far there hasn't been a textbook specific to this market, and the use of the plethora of existing engineering focused Matlab textbooks is notoriously difficult for teaching the... |
 |
Computational Modeling Methods for Neuroscientists (Computational Neuroscience) by Erik De Schutter (Editor) This book offers an introduction to current methods in computational modeling in neuroscience. The book describes realistic modeling methods at levels of complexity ranging from molecular interactions to large neural networks. A "how to" book rather than an analytical account, it focuses on the presentation of methodological approaches, including the selection of the appropriate method and its potential pitfalls. It is intended for experimental neuroscientists and graduate students who have little formal training in mathematical methods, but it will also be useful for scientists with theoretical backgrounds who want to start using data-driven modeling methods. The mathematics needed are kept to an introductory level; the first chapter explains the mathematical methods the reader needs to... |
 |
The Spiritual Brain: A Neuroscientist's Case for the Existence of the Soul by Mario Beauregard (Author), Denyse O'leary (Author) Do religious experiences come from God, or are they merely the random firing of neurons in the brain? Drawing on his own research with Carmelite nuns, neuroscientist Mario Beauregard shows that genuine, life-changing spiritual events can be documented. He offers compelling evidence that religious experiences have a nonmaterial origin, making a convincing case for what many in scientific fields are loath to consider—that it is God who creates our spiritual experiences, not the brain. Beauregard and O'Leary explore recent attempts to locate a "God gene" in some of us and claims that our brains are "hardwired" for religion—even the strange case of one neuroscientist who allegedly invented an electromagnetic "God helmet" that could produce a mystical experience in anyone who... |
| © 2009 BrightSurf.com |